This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version   RSS   Subscribe   Unsubscribe   Archive  Media Kit

Home   About   Scholarships   Meetings   Publications   Resources   January 13, 2015


New test can identify both HIV and hepatitis
U.S. authorities have approved a test developed by Swiss pharmaceutical firm Roche that can detect both HIV and hepatitis viruses. The Cobas Taqscreen MPX is the only test approved by the Food and Drug Administration that can simultaneously detect the HIV, hepatitis B and C viruses in human blood and plasma, Roche said.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Human primordial cells created in the lab
Weizmann Institute of Science via Health Canal
Groups at the Weizmann Institute of Science and Cambridge University have jointly managed the feat of turning back the clock on human cells to create primordial germ cells — the embryonic cells that give rise to sperm and ova — in the lab. This is the first time that human cells have been programmed into this early developmental stage.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Miss an issue of the eNewsBytes? Click here to visit the eNewsBytes archive page.

New stem cell technology reveals fresh insights into motor neuron disease
University of St. Andrews via Medical Xpress
Scientists at the University of St. Andrews have discovered new ways of studying what happens to motor neurons affected by motor neuron disease by using stem cells derived from patient skin samples, according to research published in Nature Communications. Motor neuron disease is a progressive neurodegenerative condition that attacks motor neurons, specialized nerve cells in the brain and spinal cord, causing the loss of signals from the brain to muscles and eventually leading to paralysis.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

California apple plant linked to deadly listeria outbreak
Strains of listeria bacteria found inside a California apple processing plant are believed to be the same ones associated with an outbreak that killed seven people and sickened dozens of others last year, federal officials said. Two strains of listeria monocytogenes were confirmed in the Bidart Bros. apple processing plant near Bakersfield, California, the Food and Drug Administration said.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  Embedded RFID Tags for Diagnostic Disposables
WEIDMANN MEDICAL TECHNOLOGY AG manufactures high-quality Wellplates of up to 1536 wells, also with thermally-bonded membranes. WEIDMANN provides innovative disposable solutions combning integrated microfluidics, specialized plastics combinations, and DMSO-resistant, partially or completely embedded RFID - inlays, barcodes and 2D-codes for product traceability.
Quality System: ISO 13485 certified.
SLAS 2015 booth: 1149 (Feb 7-11, 2015)

Do some clinical laboratory companies oversell prenatal genetic screening tests?
DARK Daily
In response to growing concerns by consumers about the accuracy of some proprietary genetic screening assays, several media outlets have begun reporting on this sector of the clinical laboratory industry. What gives these news stories emotional punch is the fact that patients use these proprietary medical laboratory tests to make decisions that can be life-changing.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Curcumin's ability to fight Alzheimer's studied
Vanderbilt University Medical Center via ScienceDaily
One of the most promising new treatments for Alzheimer's disease may already be in your kitchen. Curcumin, a natural product found in the spice turmeric, has been used by many Asian cultures for centuries, and a new study indicates a close chemical analog of curcumin has properties that may make it useful as a treatment for the brain disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

SurModics IVD - The Gold Standard
In vitro diagnostic products and technologies including protein stabilizers and blockers for immunoassays and conjugates, BioFX® colorimetric/chemiluminescent substrates, secondary antibodies, antigens from DIARECT, and activated microarray slides. MORE
Web-based competency testing
A powerful web-based program for proficiency testing of blood and body-fluid differentials. Instant access anywhere! Try it out FREE now. MORE

Who should regulate lab-developed tests?
Bloomberg BNA
The question has caused a major uproar in the health policy circles ever since July, when the Food and Drug Administration notified Congress it would propose a regulatory oversight framework for laboratory-developed tests, a type of diagnostic tests. At a two-day FDA workshop that started Jan. 8, many told the agency it didn't have the authority to regulate the tests.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

  Trust in Cleveland Clinic Laboratories
Cleveland Clinic Laboratories is a full-service, national reference lab dedicated to providing world class care. We have a dedicated staff of more than 1,300 employees, including board-certified subspecialty pathologists, PhDs, technologists, technicians, and support personnel. Cleveland Clinic Laboratories is proud to serve hospitals, outpatient facilities and physician offices worldwide. For more information, please visit

Scientists discover unanticipated consequences of some disease remedies
Infection Control Today
Parasitic worms, which infect millions of people and other animals around the world, influence how the immune system responds to diseases like HIV and tuberculosis. In a new study of African buffalo, University of Georgia ecologist Vanessa Ezenwa has found that deworming drastically improves an animal's chances of surviving bovine tuberculosis — but with the consequence of increasing the spread of tuberculosis in the population.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Get to Know Sekisui Diagnostics

We offer >65 reagents for most automated clinical chemistry systems with over one billion chemistry tests performed globally each year using our products.
Advertise here!

To find out how to feature your company in the ASCLS eNewsletter and other advertising opportunities, Contact Geoffrey Forneret at 469-420-2629.

Scientists identify new gene that drives triple-negative breast cancer
Medical News Today
Triple-negative breast cancer is when cancer growth does not involve estrogen receptors, progesterone receptors and human epidermal growth factor receptors. As such, triple-negative breast cancer does not respond to hormone therapy, meaning individuals with this subtype have a poorer prognosis than those with other subtypes. Basal cell breast cancer is the most common form of triple-negative breast cancer.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Missed last week's issue? See which articles your colleagues read most.

    CDC: Flu activity high in much of the country (Infection Control Today)
CDC lab technician still healthy after possible Ebola exposure (Center for Infectious Disease Research and Policy)
Stem cell divisions help explain cancer risk (The Scientist)
Common breast biopsy finding may be more dangerous than thought (HealthDay News)

Don't be left behind. Click here to see what else you missed.

ASCLS eNewsBytes

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Katina Smallwood, Senior Editor, 469.420.2675   
Contribute news

This edition of the ASCLS eNewsBytes was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Join ASCLS and we will subscribe you -- it's free!

Recent issues

Jan. 6, 2015
Dec. 30, 2014
Dec. 23, 2014
Dec. 16, 2014

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063